Organization
Laboratorio Elea Phoenix
3 clinical trials
Clinical trial
Randomized, Multicenter, Multinational, Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) Versus Keytruda® in Subjects With Stage IV NSCLCStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
Open-label, Multicenter, Phase II Immunotherapy Study With Racotumomab in Patients With High-risk NeuroblastomaStatus: Completed, Estimated PCD: 2022-11-01
Clinical trial
Phase III Randomized,Multicenter Non-inferiority Study to Evaluate the Efficacy and Safety of Shorter Benznidazole Regimens Compared to the Standard Regimen to Treat Adult Patients With Chronic Chagas DiseaseStatus: Recruiting, Estimated PCD: 2026-06-01